Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Inebilizumab Antibody

SKU: orb1980730

Description

Inebilizumab is a humanized monoclonal antibody targeting CD19, designed to deplete B cells via enhanced antibody-dependent cellular cytotoxicity. It is utilized in research on autoimmune conditions like neuromyelitis optica spectrum disorder and multiple sclerosis, with applications in both in vitro B cell assays and in vivo disease models.

Research Area

Immunology & Inflammation

Images & Validation

Key Properties

CAS Number1299440-37-1
MW146.60 kDa
Purity99.1% (SDS-PAGE); 96.2% (SEC-HPLC)
TargetImmunology/Inflammation related,ADC Antibody

Bioactivity

In Vivo
In vivo, Inebilizumab (MEDI-551) (i.v.; once; 0-10 mg/kg) depletes B cells from blood and spleen by mouse macrophages, and it induces phagocytosis of murine B cells ex vivo.
In Vitro
Derived from the mouse anti-human mAb HB12b, Inebilizumab had already shown impressive activity in depleting B cells in transgenic mice carrying the human CD19 gene (hCD19 Tg). Inebilizumab potently depletes CD19-expressing B cells, including primary human B cells, B cell lines derived from multiple tumor types, and neoplastic B cells. Inebilizumab demonstrates equal or better activity than Rituximab in depleting human primary B cells in autologous ADCC assays and shows potent ADCC activity against human in vitro-differentiated and primary plasma cells.

Storage & Handling

StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

VIB 0551, VIB0551, VIB-0551, Inebilizumab, MT0551, MT-0551, MT 0551, MEDI551, MEDI-551, MEDI 551, 16C4-aFuc, ADC Antibody, ADCAntibody

Similar Products

  • Inebilizumab Human Monoclonal Antibody [orb2977901]

    ELISA,  FA,  FACS,  In vivo

    Human

    Human Humanized

    Monoclonal

    Unconjugated

    100 μg, 1 mg
  • CD19 Biosimilar Antibody [orb1173649]

    ELISA,  FC

    Human

    Human Humanized

    Monoclonal

    Unconjugated

    50 μg, 100 μg
  • Inebilizumab (CD19) - Research Grade Biosimilar Antibody [orb1237617]

    Recombinant

    Unconjugated

    0.1 mg
  • Inebilizumab (FUT8-KO) Antibody [orb2665742]

    Monoclonal

    Unconjugated

    5 mg, 1 mg, 10 mg
  • CD19 Biosimilar Antibody [orb2670837]

    FC

    Human

    Human Humanized

    Monoclonal

    PE

    100 T
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Inebilizumab Antibody (orb1980730)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
¥ 2,600.00
5 mg
¥ 5,720.00
10 mg
¥ 9,100.00
25 mg
¥ 13,390.00
50 mg
¥ 18,200.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry